RT Journal Article
SR Electronic
T1 Early phases of COVID-19 are characterized by a reduction of lymphocyte populations and the presence of atypical monocytes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.01.20087080
DO 10.1101/2020.05.01.20087080
A1 Andrea Lombardi
A1 Elena Trombetta
A1 Alessandra Cattaneo
A1 Valeria Castelli
A1 Emanuele Palomba
A1 Mario Tirone
A1 Davide Mangioni
A1 Giuseppe Lamorte
A1 Maria Manunta
A1 Daniele Prati
A1 Ferruccio Ceriotti
A1 Roberta Gualtierotti
A1 Giorgio Costantino
A1 Stefano Aliberti
A1 Vittorio Scaravilli
A1 Giacomo Grasselli
A1 Andrea Gori
A1 Laura Porretti
A1 Alessandra Bandera
A1 for the COVID-19 Network
YR 2020
UL http://medrxiv.org/content/early/2020/05/06/2020.05.01.20087080.abstract
AB Background Severe acute respiratory syndrome coronavirus 2 is a recently discovered pathogen responsible of coronavirus disease 2019 (COVID-19). The immunological changes associated with this infection are largely unknown.Methods We evaluated the peripheral blood mononuclear cells profile of 63 patients with COVID-19 at diagnosis and the presence of association with inflammatory biomarkers and 28-days mortality.Results Lymphocytopenia was present in 51 of 63 (80.9%) patients. This reduction was mirrored also on CD8+ lymphocytes (128 cells/μL), natural killer cells (67 cells/μL) and natural killer T cells (31 cells/μL). Monocytes were preserved in total number but displayed a subpopulation composed mainly of cells with a reduced expression of both CD14 and HLA-DR. A direct correlation was found between serum values of IL-6 and the frequency of Th2 lymphocytes (R=0.17; p=0.04) but not with the monocytes count (R=0.01; p=0.60). Patients who died in the 28 days from admission (N=10, 15.9%), when compared to those who did not, displayed lower mean values of CD3+ (p=0.028) and CD4+ cells (p=0.042) and higher mean percentages of CD8+/CD38+/HLA-DR+ lymphocytes (p=0.026).Conclusions The early phases of COVID-19 are characterized by lymphocytopenia, predominance of Th2 lymphocytes and less immunocompetent monocytes, which include atypical mononuclear cells.eTOC-At diagnosis patients with COVID-19 have lymphocytopenia-Monocytes with both normal or altered scatter properties display a reduced expression of CD14 and HLA-DR in most of COVID-19 patients-Patients who die in the 28 days from admission have lower values of CD3+ and CD4+ cells and higher percentages of activated CTL cells compared to those who surviveCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe grant “COVID-19 Biobank” was provided by the Scientific Direction, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAlla data reported are available for further analysis.